Sylvia Stadlmann Selected Research

Antibodies

4/2022

High ratio of pCXCR4/CXCR4 tumor infiltrating immune cells in primary high grade ovarian cancer is indicative for response to chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvia Stadlmann Research Topics

Disease

14	Neoplasms (Cancer) 04/2022 - 05/2005
10	Ovarian Neoplasms (Ovarian Cancer) 04/2022 - 06/2005
9	Carcinoma (Carcinomatosis) 04/2022 - 06/2005
3	Liver Diseases (Liver Disease) 06/2008 - 08/2005
2	Tics (Tic) 04/2022 - 11/2021
2	Hepatitis 11/2012 - 08/2006
2	Wounds and Injuries (Trauma) 11/2012 - 01/2004
2	Hepatocellular Carcinoma (Hepatoma) 06/2008 - 02/2007
2	Liver Failure 01/2006 - 01/2004
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2004 - 05/2002
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Small Cell Carcinoma 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Adenocarcinoma 01/2021
1	Testicular Neoplasms (Testicular Cancer) 05/2013
1	Abscess 02/2012
1	Suppuration 02/2012
1	Insulin Resistance 10/2009
1	Alcoholic Fatty Liver 10/2009
1	Weight Loss (Weight Reduction) 10/2009
1	Non-alcoholic Fatty Liver Disease 10/2009
1	Carcinogenesis 01/2007
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2006
1	Inflammation (Inflammations) 01/2006
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2005
1	Hyperferritinemia 08/2005
1	Iron Overload 08/2005
1	type 4 Hemochromatosis 08/2005
1	Ascites 06/2005
1	Peritoneal Diseases 06/2005

Drug/Important Bio-Agent (IBA)

5	PlatinumIBA 08/2013 - 01/2007
3	Interleukin-17 (Interleukin 17)IBA 01/2018 - 08/2013
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2009
2	Formaldehyde (Formol)FDA Link 01/2016 - 08/2013
2	ParaffinIBA 01/2016 - 08/2013
2	GlypicansIBA 06/2008 - 07/2007
2	Proteins (Proteins, Gene)FDA Link 03/2007 - 04/2006
2	CytokinesIBA 01/2006 - 06/2005
1	AntibodiesIBA 04/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Therapeutic UsesIBA 01/2020
1	TinIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Peroxidase (Myeloperoxidase)IBA 01/2016
1	Bromodeoxyuridine (BrdU)IBA 02/2014
1	AntigensIBA 05/2013
1	Monoclonal AntibodiesIBA 05/2013
1	Biological ProductsIBA 05/2013
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 11/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2012
1	AdiponectinIBA 10/2009
1	ResistinIBA 10/2009
1	Adiponectin ReceptorsIBA 10/2009
1	Leptin ReceptorsIBA 10/2009
1	Nicotinamide PhosphoribosyltransferaseIBA 10/2009
1	AdipokinesIBA 10/2009
1	Protein Isoforms (Isoforms)IBA 10/2009
1	LeptinIBA 10/2009
1	PPAR gammaIBA 03/2007
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2007
1	Transcription Factors (Transcription Factor)IBA 01/2007
1	E2F Transcription FactorsIBA 01/2007
1	Clopidogrel (Plavix)FDA Link 08/2006
1	Growth Factor ReceptorsIBA 04/2006
1	ErbB Receptors (EGF Receptor)IBA 04/2006
1	DNA (Deoxyribonucleic Acid)IBA 04/2006
1	Asparaginase (Elspar)FDA Link 01/2006
1	IronIBA 08/2005
1	HemosiderinIBA 08/2005
1	metal transporting protein 1 (ferroportin)IBA 08/2005
1	HepcidinsIBA 08/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2005
1	EnzymesIBA 06/2005
1	ImmunosorbentsIBA 06/2005
1	PhosphoserineIBA 05/2005
1	Carrier Proteins (Binding Protein)IBA 05/2005
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2004
1	nimesulide (Aulin)IBA 05/2002
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2002

Therapy/Procedure

9	Drug Therapy (Chemotherapy) 04/2022 - 03/2007
6	Therapeutics 08/2013 - 08/2006
1	Immunotherapy 05/2013
1	Catheters 02/2012
1	Bariatric Surgery 10/2009
1	Liver Transplantation 02/2007
1	Stents 08/2006
1	Combination Drug Therapy (Combination Chemotherapy) 01/2006